Outcome of the Meeting of Board of Directors held on 12th August, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Zenith Healthcare approved the unaudited financial results for the quarter ended June 30, 2025. Revenue from operations rose about 22.5% YoY to Rs 315.11 lakhs (from Rs 257.13 lakhs), and total income grew to Rs 331.69 lakhs. However, total expenses jumped ~34% to Rs 334.30 lakhs, driven mainly by higher other expenses (Rs 126.72 lakhs vs Rs 98.50 lakhs) and inventory changes. The company swung from a net profit of Rs 15.61 lakhs in Q1 FY25 to a net loss of Rs 1.88 lakhs in Q1 FY26, with EPS turning negative at (Rs 0.003). The statutory auditor (Doshi Doshi & Co) issued an unmodified limited review report.
Despite top-line growth, sharply higher costs wiped out profits, pushing the company into a small quarterly loss — a negative signal for near-term earnings quality. Shareholders should watch for cost control and whether revenue momentum translates into profit recovery in coming quarters.